Workshop: Industrialization of Cell Therapy Manufacturing—Lessons Learned from Biologics

Connecting insights across industries: watch our workshop

At the Cell and Gene Meeting on the Mesa 2021, experts in the fields of cell and gene therapy, biotech, and supply chain, came together to discuss the challenges and opportunities around cell therapy manufacturing, and the lessons to be learned from biologics.

During this 90-minute in-person workshop, our speakers shared insights into:

  •  Innovations in fit-for-purpose closed manufacturing systems
  • The need to move from small scale, open workflows into closed, scalable automated flows

  •  Controlling critical process parameters with digital integration
  • Using automation to address process, efficiency, robustness, safety, quality and cost

  •  Whether we should standardize our approach to analytics
  • A deep dive into standardization as applied to analytics, in process analytics and QC analytics, and the lessons to be learned from biologics

  •  Overcoming supply chain challenges in a post-pandemic world
  • The ways in which the pandemic forced us all to be more efficient and thoughtful in the ways that we  approach supply chain considerations and opportunities


Cell therapy solutions

Learn more about cell therapy solutions

Connect to the integrated solutions that support your cell therapy development at every stage. Your success is our goal. By providing you with high-quality materials, services, and support, we can help you translate your cell therapy from discovery to clinical research all the way through to cell therapy commercialization.

Learn more about cell therapy solutions

Find cell therapy products and solutions

Cell therapy manufacturing scientist in full PPE examining therapeutic vile in support of car t cell therapy process

Explore a wide-range of cell and gene therapy products and solutions from discovery to commercialization that will help you accelerate your therapeutic development.

Browse now

Request more information

Artist rendition of a cell with adeno-associated virus (AAV particles) as part of a cell and gene therapy solution

We’re here to help accelerate the pace of cell and gene therapy development. We offer high-quality solutions for every stage of development, regulatory documentation and support, and access to expert consultation—allowing for seamless transition from basic research to the clinic and commercialization. Tell us how we can help, and request information from our team of specialists.

Request information